Micro Systemation AB (publ) (FRA:W98)
| Market Cap | 140.65M +47.8% |
| Revenue (ttm) | 46.14M +25.4% |
| Net Income | 6.33M +129.1% |
| EPS | 0.34 +128.3% |
| Shares Out | n/a |
| PE Ratio | 22.23 |
| Forward PE | 21.09 |
| Dividend | 0.14 (1.81%) |
| Ex-Dividend Date | May 13, 2026 |
| Volume | n/a |
| Open | 7.54 |
| Previous Close | 7.44 |
| Day's Range | 7.54 - 7.58 |
| 52-Week Range | 4.78 - 7.84 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 16, 2026 |
About Micro Systemation AB
Micro Systemation AB (publ), together with its subsidiaries, provides forensic technology for mobile device examination and analysis in Sweden and internationally. The company offers XRY software products that include XRY logical, a software solution that enables investigators to access and recover live and file system data from the device on the crime scene; XRY Physical, a software solution, which is used for the physical recovery of data from mobile devices; XRY Pro, a full toolkit for extraction and decryption of secure devices; XRY Cloud t... [Read more]
Financial Performance
In 2025, Micro Systemation AB's revenue was 461.78 million, an increase of 14.10% compared to the previous year's 404.71 million. Earnings were 49.17 million, an increase of 31.51%.
Financial numbers in SEK Financial StatementsNews
Micro Systemation AB Earnings Call Transcript: Q2 2026
Q2 delivered 50% sales growth and a return to profitability, with strong gross margins and robust expansion in EMEA and APAC. Continued investment in products and emerging markets is expected, with a positive outlook for the year.
Micro Systemation AB Quarterly report: Q2 2026
Micro Systemation AB has published its Q2 2026 quarterly earnings report on July 16, 2026.
Earnings To Watch: Micro Systemation AB (OSTO:MSAB B) Reports Q2 2026 Result
Earnings To Watch: Micro Systemation AB (OSTO:MSAB B) Reports Q2 2026 Result
Micro Systemation AB Transcript: CMD 2026
Long-term targets include SEK 1 billion revenue and SEK 200 million EBITDA by 2030, with a focus on software, AI-driven innovation, and expansion in APAC and new verticals. The company is leveraging a scalable model, strong product suite, and low churn to drive growth, while adapting to a rapidly evolving competitive and technological landscape.
Micro Systemation AB Press release: FY 2026
Micro Systemation AB issued a press release on May 7, 2026, disclosing material business information to investors.
Micro Systemation AB Slides: FY 2026
Micro Systemation AB has posted slides in relation to its FY 2026 quarterly earnings report, which was published on May 7, 2026.
Micro Systemation AB Earnings Call Transcript: Q1 2026
Record Q1 sales and strong FX-adjusted growth were driven by XRY Pro and new contract wins, with stable gross margins and a debt-free balance sheet. Investments in products and organization will weigh on 2026 profitability, but scalability is expected to improve thereafter.
Micro Systemation AB Quarterly report: Q1 2026
Micro Systemation AB has published its Q1 2026 quarterly earnings report on April 28, 2026.
Micro Systemation AB Earnings Call Transcript: Q4 2025
Record revenue and profit growth driven by strong product investments and regional expansion, with APAC and EMEA leading performance. Continued focus on innovation and high-potential markets, while U.S. sales face headwinds from budget cuts and shutdowns.
Micro Systemation AB Quarterly report: Q4 2025
Micro Systemation AB has published its Q4 2025 quarterly earnings report on January 27, 2026.
Micro Systemation AB Annual report: Q4 2025
Micro Systemation AB has published its Q4 2025 annual report on January 27, 2026.
Micro Systemation AB Earnings Call Transcript: Q3 2025
Record quarterly revenue and EBIT driven by strong growth in EMEA and APAC, with XRY Pro sales leading upgrades. U.S. government shutdown may delay Q4 orders, but overall outlook remains positive and ahead of the 2025 plan.
Micro Systemation AB Quarterly report: Q3 2025
Micro Systemation AB has published its Q3 2025 quarterly earnings report on October 28, 2025.